RxFul vs BoomRx

RxFul vs BoomRx

RxFul and BoomRx both serve cash-pay clinics but with different scope and buyer UX. RxFul is white-label pharmacy fulfillment infrastructure — clinic-branded patient checkout, licensed 503A partners, tiered SaaS from $0 through $1,997 per month, and bundled 3PL logistics. BoomRx is a national pharmaceutical technology platform that unifies ordering across 503A patient-specific, 503B office-use, and brand medications through one procurement portal with consolidated flat-rate shipping and API integrations marketed for scaling telehealth brands. Clinics that need pass-through per-vial cost before checkout and a patient-linked prescriber batch cart often compare Fizy Health alongside both.

If you are choosing between patient-portal infrastructure and a broad procurement hub like BoomRx, this page compares RxFul and BoomRx and shows where a pass-through platform like Fizy Health fits.

Compare Fizy Health vs RxFul

Proudly Partnered With

RxFul vs BoomRx

RxFul vs BoomRx, capability by capability.

RxFul centers on clinic-branded patient checkout and 503A fulfillment infrastructure. BoomRx centers on unified multi-category procurement across a national partner network. The comparison is patient-facing portal versus broad clinic procurement.

Platform model
RxFulWhite-label patient portal and 503A orchestration tech with 3PL logistics — not a pharmacy.
BoomRxPharmaceutical technology platform: unified ordering over 503A, 503B, and brand medication partners.
Primary buyer UX
RxFulPatient-facing branded portal for checkout, tracking, and fulfillment comms.
BoomRxClinic procurement portal spanning compounded, office-use, and brand medications.
Catalog scope
RxFulGLP-only on free Rx-GLP tier; full SKU catalog on Bronze ($997/mo) and above.
BoomRxHundreds of 503A formulary products plus 503B outsourcing and brand medications in one dashboard.
503B office-use bulk
RxFul503A patient-specific focus; 503B access varies by partner and tier.
BoomRxNational network of regulated 503A compounders and FDA-registered 503B facilities via partners.
Pricing visibility
RxFulTiered SaaS ($0, $997, $1,497, $1,997/mo) plus volume-based fulfillment on Silver+.
BoomRxCompetitive pricing in portal; marketing claims average savings versus industry — confirm on your SKUs.
Shipping model
RxFul3PL fulfillment bundled as single point of contact under clinic brand.
BoomRxConsolidated flat-rate shipping across partner pharmacies; state eligibility shown in portal.
Multi-patient batch checkout
RxFulPatient-portal workflows; not prescriber batch-cart native for whole refill lists.
BoomRxUnified procurement portal; procurement-first workflow across the partner network.
Pre-submit validation
RxFulStandard portal and fulfillment review rather than advertised pre-submit cart validation.
BoomRxCoordinated fulfillment workflow; pre-submit cart validation not prominently advertised.
  • When RxFul fits

    You are launching or scaling a patient-facing DTC checkout and need clinic-branded portal UX with tiered SaaS packaging and 3PL fulfillment under your own brand.

  • When BoomRx fits

    You are evaluating a signup-gated procurement portal while you still buy mostly 503B office stock and brand medications from one hub, and flat consolidated shipping matters more than patient-linked batch checkout.

  • When Fizy Health fits

    Your prescribers batch patient-specific 503A refills and need pass-through per-vial cost before checkout, validation before payment, and one HIPAA-audited cart across multiple 503A partners.

RxFul feature and pricing data from rxful.com (June 2026). BoomRx details from boomrx.com and PR Newswire press releases (Dec 2025, Mar 2026). Fizy Health capabilities reflect the live product.

Patient portal infrastructure versus unified procurement

RxFul and BoomRx reduce pharmacy complexity through different lenses. RxFul packages white-label patient checkout, 503A partner orchestration, and 3PL logistics so patients order under your clinic brand. BoomRx packages procurement across 503A, 503B, and brand medications into one portal with flat-rate shipping and integrations aimed at telehealth brands scaling nationally.

Pick by what your clinic actually buys and who places the order. A brand building patient self-checkout may lean RxFul. A multi-location operator sourcing office-use and brand supply through one login may lean BoomRx — and either way, compare your top five SKUs on landed cost before you commit, not headline savings claims alone.

Where Fizy Health changes the comparison

Fizy Health is a prescriber-first clinic ordering platform focused on patient-specific 503A lines. It shows resolved per-vial cost on every catalog and cart row before checkout, validates SIGs and licensure before payment, and batches every patient who needs an order today in one HIPAA-audited cart. It does not replace a 503B office-use procurement hub — confirm whether your formulary is on Fizy Health today if you rely on office-use bulk only.

RxFul, BoomRx, or a pass-through platform — which fits your clinic?

RxFul fits if

RxFul

You need clinic-branded patient checkout and white-label portal infrastructure.

  • You are launching or scaling a patient-facing DTC checkout under your clinic brand.
  • Tiered SaaS with bundled fulfillment fits your budget model more than prescriber-side batch carts.
  • Your priority is patient-brand infrastructure — not a unified 503B procurement hub.
Consider Fizy Health if

Fizy Health

Patient-linked batch cart with pass-through 503A pricing before checkout.

  • You batch dozens of GLP-1, hormone, or peptide refills and need one session for the whole patient list.
  • You want pass-through per-vial 503A cost visible before you quote cash-pay patients — compare landed cost on the same SKUs.
  • Every cart line must tie to a patient with audited access, not just consolidated procurement.
FAQ

RxFul vs BoomRx questions.

  • Model

    Are RxFul and BoomRx the same kind of platform?

    Not quite. RxFul is white-label patient portal and 503A fulfillment infrastructure. BoomRx is a unified procurement portal spanning 503A, 503B, and brand medications with flat-rate shipping.

  • Scope

    Which one covers 503B office-use bulk?

    BoomRx explicitly markets 503A and 503B network access. RxFul centers on 503A patient-specific ordering with tiered portal packaging. Fizy Health focuses on 503A patient-specific ordering — confirm whether your formulary is on Fizy Health today if you rely on 503B office-use only.

  • Pricing

    Does RxFul or BoomRx show pricing up front?

    RxFul publishes tiered SaaS ($0 through $1,997/mo) with full catalog from $997/mo. BoomRx shows competitive pricing in portal after signup. Fizy Health shows resolved per-vial 503A cost in catalog and cart before checkout.

  • Buyer UX

    Which one is patient-facing?

    RxFul's core product is a clinic-branded patient portal for checkout and tracking. BoomRx is a clinic procurement portal. Fizy Health is prescriber-first — clinic staff batch orders in one cart.

  • Validation

    Does either catch order errors before submission?

    Neither RxFul nor BoomRx highlights pre-submit cart validation in public marketing. Fizy Health runs cart validation before checkout to catch invalid SIGs, licensure mismatches, and stock gaps before you pay.

  • Alternative

    Where does Fizy Health fit between RxFul and BoomRx?

    Fizy Health is a prescriber-first 503A ordering platform with pass-through per-vial pricing before checkout, validation before payment, and patient-linked batch checkout — a different layer than patient-portal branding or broad 503B procurement.

Sources reviewed June 2026

  • RxFul public website and pricing pages (rxful.com), reviewed June 2026.
  • BoomRx public website and PR Newswire press releases (boomrx.com), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Compare pass-through pricing against both options.

See resolved per-vial 503A cost before you quote, with validation before you pay and one patient-linked batch cart. Free to start.